An ad hoc committee will plan and host a 1.5-day public workshop to facilitate discussion focused on the translation of federal investments in biomedical science to innovation in drug development and how the public benefits from that investment in terms of drug pricing and access. The meeting will feature invited presentations and panel discussions on topics that may include:
The planning committee will develop the agenda, select and invite subject-matter experts and discussants, and moderate the discussions. A proceedings of the event will be prepared in accordance with institutional guidelines.